Hong Shu Selected Research

Hong Shu Research Topics

Disease

17	Neoplasms (Cancer) 02/2022 - 02/2005
13	Hepatocellular Carcinoma (Hepatoma) 11/2021 - 04/2010
10	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 07/2009
9	Pancreatic Neoplasms (Pancreatic Cancer) 11/2014 - 01/2011
6	Fibrosis (Cirrhosis) 01/2021 - 04/2010
5	Infections 07/2020 - 12/2007
4	Neoplasm Metastasis (Metastasis) 09/2017 - 08/2009
4	Allergic Rhinitis 01/2010 - 03/2006
3	Hemolysis 02/2021 - 06/2019
3	HELLP Syndrome 02/2021 - 06/2019
3	Ischemia 05/2011 - 09/2008
2	Carcinogenesis 01/2022 - 10/2020
2	Pathologic Processes 11/2021 - 01/2021
2	Liver Neoplasms (Liver Cancer) 01/2020 - 07/2009
2	Acute Kidney Injury (Acute Renal Failure) 07/2019 - 06/2019
2	Lymphatic Metastasis 08/2012 - 11/2009
2	Liver Diseases (Liver Disease) 07/2011 - 05/2011
2	Inflammation (Inflammations) 05/2011 - 09/2008
2	Vasomotor Rhinitis 03/2008 - 10/2007
1	Laryngo onycho cutaneous syndrome 03/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Uveal melanoma 01/2022
1	Pre-Eclampsia (Preeclampsia) 02/2021
1	Postpartum Hemorrhage 02/2021
1	Acute-Phase Reaction 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Pain (Aches) 01/2021
1	Hemangioma (Angioma) 10/2020
1	Atopic Dermatitis (Atopic Eczema) 01/2020
1	Fever (Fevers) 10/2019
1	Osteolysis 10/2019
1	Eclampsia 07/2019
1	Isolated Systolic Hypertension 07/2019
1	Anuria 06/2019
1	Glioblastoma (Glioblastoma Multiforme) 09/2017
1	Edema (Dropsy) 09/2017
1	Pulmonary Arterial Hypertension 09/2017
1	Adenocarcinoma 01/2017
1	Genomic Instability 06/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2013

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2007
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2009
7	HaptoglobinsIBA 11/2021 - 07/2009
5	Polysaccharides (Glycans)IBA 01/2022 - 03/2008
4	EnzymesIBA 02/2021 - 06/2006
3	GlycopeptidesIBA 11/2021 - 01/2021
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2021 - 02/2005
3	Aryldialkylphosphatase (Paraoxonase)IBA 01/2021 - 01/2017
3	Gemcitabine FDA Link 01/2014 - 07/2013
3	CytokinesIBA 06/2009 - 03/2003
2	Pharmaceutical PreparationsIBA 02/2022 - 11/2014
2	Fetal Proteins (Fetoprotein)IBA 01/2021 - 11/2010
2	Long Noncoding RNAIBA 10/2020 - 01/2020
2	AutoantibodiesIBA 01/2020 - 10/2019
2	Epidermal Growth Factor (EGF)IBA 09/2017 - 10/2014
2	ErbB Receptors (EGF Receptor)IBA 09/2017 - 04/2014
2	Fluorouracil (Carac)FDA LinkGeneric 11/2014 - 01/2011
2	MicroRNAs (MicroRNA)IBA 08/2013 - 02/2012
2	StathminIBA 08/2011 - 04/2010
2	ProteomeIBA 11/2010 - 08/2010
2	EndotoxinsIBA 06/2009 - 09/2008
1	Biological ProductsIBA 03/2022
1	DNA (Deoxyribonucleic Acid)IBA 03/2022
1	elaiophylinIBA 01/2022
1	Sirtuin 1IBA 01/2022
1	Sialic AcidsIBA 11/2021
1	Glycoproteins (Glycoprotein)IBA 11/2021
1	C-Reactive ProteinIBA 01/2021
1	Antithrombin IIIIBA 01/2021
1	arylesteraseIBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	LectinsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 10/2020
1	ginsenoside Rg3IBA 07/2020
1	Antiviral Agents (Antivirals)IBA 07/2020
1	EmollientsIBA 01/2020
1	InterferonsIBA 10/2019
1	Hemoglobins (Hemoglobin)IBA 07/2019
1	CreatinineIBA 07/2019
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 09/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2016
1	ParaffinIBA 10/2014
1	Formaldehyde (Formol)FDA Link 10/2014
1	ThiazolesIBA 06/2014
1	human CDC7 proteinIBA 06/2014
1	Phosphotransferases (Kinase)IBA 06/2014
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 04/2014
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2014
1	Insulin-Like PeptidesIBA 01/2014
1	3- (5- nitrofuryl)- 7- (5- nitrofurfurylidene)- 3,3a,4,5,6,7- hexahydro- 2H- indazoleIBA 12/2013
1	Acetyl-CoA CarboxylaseIBA 12/2013

Therapy/Procedure

3	Therapeutics 01/2022 - 11/2010
2	Ligation 05/2011 - 09/2008
2	Immunotherapy 01/2010 - 03/2006
1	Microbubbles 02/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 06/2019